What to Do When Mounjaro Stops Working (October 2026)

01 · The core answer

Is Mounjaro really not working, or have you hit a plateau?

In most cases it is a plateau. Weight loss on Mounjaro is not linear, and stalls of a few weeks are normal as the body adapts to a lower weight.¹ A plateau is a pause in a trend that is otherwise heading the right way. Genuine non-response is judged over a longer window and by your prescriber, not by a bad fortnight.

Work through it from the top, because the simplest causes are the commonest.

02 · Your next step

What do you do when Mounjaro stops working?

Start by checking the basics, then involve your prescriber. Within the licence, the responses are to review food intake honestly because portions drift back up, protect protein and activity, check the basics such as sleep and alcohol, and discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.¹

A plateau is not a reason to double doses or add unlicensed products.¹ Those shortcuts add risk without evidence behind them.

If you are a customer, your monthly review is the right place to raise a stall. If you are considering a regulated private route, you can read about the Mounjaro pen and its prices; the standard price of a 7.5mg pen is £244.99 per month, and a 10mg pen is £274.99. New customers save £40 on their first order with code FIRST40, and every later order is £25 off the standard price. Our wider weight loss clinic page explains the full service.

03 · Why plateaus happen

Why Mounjaro seems to stop working: the usual reasons

The usual reasons are physiological adaptation, an unfinished dose ladder and gradual habit drift. As you lose weight, your body needs less energy, so the same food intake that produced a loss at a higher weight produces less change at a lower one. That is an adaptation, not the medicine failing.

Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1, which helps regulate appetite and slows how quickly the stomach empties.¹ Those actions continue every week you take it. What changes over time is the context around the medicine: your weight, your routines and how closely you are following the reduced-calorie diet it is designed to support.

Early loss also includes water weight, so the early drop can look dramatic and then seem to slow. The trend over weeks matters more than any single weigh-in. Scales also move with salt, hormones, constipation and hydration, none of which reflect fat change.

If you are weighing yourself daily and reacting to each number, move to a weekly weigh-in at the same time of day, and add a waist measurement and how your clothes fit. These give a calmer, more accurate picture than the scales alone.

04 · Tolerance and dose

Can you build a tolerance, and is your dose too low?

Plateaus of a few weeks are normal and expected as the body adapts to a lower weight. The more common issue is that people are still on a lower strength than the one they respond to.

Weight loss on Mounjaro is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.¹ Slower early progress does not predict failure, and the dose you respond to may still be ahead of you.

In SURMOUNT-1, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages and individual results vary. The pattern still shows that averages rise with dose, which is why a step-up is worth discussing if you are not at maximum.

Higher strengths are not automatically right for everyone. Side effects matter, and your prescriber balances benefit against how well you tolerate each step. In SURMOUNT-1, 4.3% of people on 5mg, 7.1% on 10mg and 6.2% on 15mg stopped treatment because of side effects, compared with 2.6% on placebo.²

Dose steps are made by your prescriber, at a minimum of 4-week intervals, depending on how you respond and tolerate it. Do not move up on your own because the scales have stalled.

05 · Habits to recheck

The habits to recheck before blaming the medicine

Recheck food, protein, movement, sleep and alcohol, in that order. Mounjaro makes you feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ It does not remove calories by itself, and appetite that feels quiet can hide gradually bigger portions, liquid calories and grazing.

Food. Keep an honest diary for a short spell. Include oils, sauces, drinks, snacks and bites while cooking. Many people find that portions have crept back up without any sense of hunger.

Protein. Protecting protein helps you hold on to muscle while losing weight, and it keeps meals satisfying when your appetite is small. Build each meal around a protein source, and ask your prescriber or a dietitian if you are unsure how much suits you.

Activity. Increased physical activity is part of the licence, not an optional extra. The evidence-backed pattern is regular moderate activity, such as brisk walking, plus resistance work for muscle. Start where you are and build; on injection days with early side effects, lighter movement still counts.¹

Sleep and alcohol. Poor sleep tends to raise appetite and cut energy for exercise, and alcohol adds calories while lowering restraint at mealtimes. Both are easy to overlook and straightforward to adjust.

Injection routine. Mounjaro is licensed as a once-weekly medicine, with blood levels designed around a seven-day cycle.¹ Pick a consistent day, keep pens in the fridge, and a pen in use can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, then must be thrown away.¹³ If you have missed doses, tell your prescriber rather than guessing how to catch up.

06 · Reviewing your response

When your prescriber should formally review your response

A formal review is appropriate when you have given the highest tolerated dose a fair run and progress remains limited. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹

That is a conversation, not an automatic verdict. Your prescriber will look at which dose you have actually reached, how consistent you have been, how you are tolerating treatment and your overall health. Bring your weekly weights, waist measurements and a short food and activity diary so the discussion is based on facts.

It is also worth looking beyond the scales. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures.² These are trial averages, not promises, but they show why a stall on the scales is not the whole story of how treatment is helping.

Customers of our service have ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, plus side-effect support. Repeat orders re-check suitability, and nothing ships automatically. The GLPTrackr companion app can help you keep weights and doses in one place before a review.

07 · What not to do

What not to do when your weight stalls

Do not self-adjust. A plateau is not a reason to double doses or add unlicensed products.¹

Do not stop suddenly in frustration either. Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.¹⁴ Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.

For more on what follows a break in treatment, read our guide on what happens when use stops.

Finally, if you notice a new symptom while your weight is stalled, report it to your prescriber and consider reporting it through the Yellow Card scheme.¹⁹

08 · Switching and other options

Should you switch medicine if Mounjaro seems to stall?

Switching is a prescriber decision and rarely the first answer. If you have hit a plateau on tirzepatide, the licensed steps are the habit review and the dose conversation. Moving to a different medicine does not remove the adaptation to a lower weight, so a stall on one treatment can follow you to another.

That said, there are reasons a prescriber may discuss alternatives: side effects that limit your dose, a medical change, or a clear lack of response at the highest tolerated dose after a fair trial. Our own guidance on the reverse situation is in what to consider if semaglutide stops working. A broader explanation of why these medicines can seem to fade is in our piece on whether GLP-1 medicines stop working.

If you are thinking about a different product altogether, be cautious with supplements marketed as natural alternatives. They are not medicines, are not regulated for this use and have no comparable trial evidence; they are available cheaply without assessment and offer no clinical oversight. Dramatic weight-loss claims on such products should be treated sceptically.

NHS access is also an option if you meet the criteria. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴

09 · Realistic expectations

Setting realistic expectations to avoid a false alarm

Many apparent failures are really expectations that were too fast. Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures. A sensible expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.¹

In SURMOUNT-1, average weight loss built month by month, with the full averages measured at 72 weeks, not at the three-month mark.² Think in months, not days, and judge progress by trend, not individual weigh-ins.

Remember also that the trial figures are averages. Some people lose more, some less, and your own result is shaped by your starting point, your dose, your health and your daily habits. If you are comparing yourself with someone online, you are comparing different bodies on different doses at different stages.

The first weeks can be quiet. Experiences differ widely: some people notice appetite change and early loss in the first week, others feel little until a higher dose, and both are normal. If you are still near the start, our guides on when the starter dose starts working and how timelines compare with Wegovy may reassure you.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Report any suspected side effect through the Yellow Card scheme. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹